Literature DB >> 10340962

Autocrine control of vitamin D metabolism in synovial cells from arthritic patients.

S J Smith1, M E Hayes, P L Selby, E B Mawer.   

Abstract

OBJECTIVE: This study was designed to investigate whether 1, 25-dihydroxyvitamin D3 (1,25-(OH)2D3), produced by activated synovial fluid macrophages, promotes its own catabolism by upregulating vitamin D-24-hydroxylase (24-OHase) in synovial fibroblasts through a vitamin D receptor (VDR) mediated mechanism.
METHODS: Synovial macrophages and fibroblasts were derived from patients with rheumatoid arthritis. Expression of VDR and 24-OHase mRNAs was determined using in situ hybridisation. Vitamin D hydroxylase activity was determined by incubating cells with [3H]-25-(OH)D3, or [3H]-1,25-(OH)2D3, and metabolite synthesis quantified using high performance liquid chromatography.
RESULTS: 1, 25-(OH)2D3 increased expression of mRNA for both VDR and 24-OHase in fibroblasts by approximately threefold over 24 hours. 1,25-(OH)2D3 increased fibroblast 24-OHase activity, yielding 24-hydroxylated, and more polar, metabolites. In co-culture, fibroblasts were able to catabolise macrophage derived 1,25-(OH)2D3.
CONCLUSIONS: 1, 25-(OH)2D3 is produced by macrophages in vitro at biologically relevant concentrations and can increase its own catabolism by synovial fibroblasts; this effect is probably mediated via upregulation of both synovial fibroblast VDR and 24-OHase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340962      PMCID: PMC1752897          DOI: 10.1136/ard.58.6.372

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  18 in total

1.  Detection of canine distemper virus in bone cells in the metaphyses of distemper-infected dogs.

Authors:  A P Mee; D M Webber; C May; D Bennett; P T Sharpe; D C Anderson
Journal:  J Bone Miner Res       Date:  1992-07       Impact factor: 6.741

2.  1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine.

Authors:  M F Holick; A Kleiner-Bossaller; H K Schnoes; P M Kasten; I T Boyle; H F DeLuca
Journal:  J Biol Chem       Date:  1973-10-10       Impact factor: 5.157

3.  Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: a pilot study.

Authors:  D Huckins; D T Felson; M Holick
Journal:  Arthritis Rheum       Date:  1990-11

4.  Differential metabolism of 25-hydroxyvitamin D3 by cultured synovial fluid macrophages and fibroblast-like cells from patients with arthritis.

Authors:  M E Hayes; D Bayley; P Still; J Palit; J Denton; A J Freemont; R G Cooper; E B Mawer
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

5.  A sensitive radioimmunoassay using a monoclonal antibody that is equipotent for ercalcitriol and calcitriol (1,25-dihydroxy vitamin D2 and D3).

Authors:  E B Mawer; J L Berry; J P Cundall; P E Still; A White
Journal:  Clin Chim Acta       Date:  1990-10-15       Impact factor: 3.786

6.  Inhibition by prostaglandin E1 and E2 of 1,25-dihydroxyvitamin D3 synthesis by synovial fluid macrophages from arthritic joints.

Authors:  M E Hayes; A Rai; R G Cooper; D Bayley; A J Freemont; E B Mawer
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

7.  1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis.

Authors:  M T Cantorna; C E Hayes; H F DeLuca
Journal:  J Nutr       Date:  1998-01       Impact factor: 4.798

8.  Synthesis of the active metabolite of vitamin D, 1,25(OH)2D3, by synovial fluid macrophages in arthritic diseases.

Authors:  M E Hayes; J Denton; A J Freemont; E B Mawer
Journal:  Ann Rheum Dis       Date:  1989-09       Impact factor: 19.103

9.  1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis.

Authors:  J M Lemire; D C Archer
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

10.  Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis.

Authors:  E B Mawer; M E Hayes; P E Still; M Davies; G A Lumb; J Palit; P J Holt
Journal:  J Bone Miner Res       Date:  1991-07       Impact factor: 6.741

View more
  3 in total

1.  The vitamin D receptor regulates rheumatoid arthritis synovial fibroblast invasion and morphology.

Authors:  Teresina Laragione; Anish Shah; Pércio S Gulko
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

Review 2.  In sickness and in health: pivotal role of vitamin D.

Authors:  Nora Nikolac Gabaj; Adriana Unic; Marijana Miler; Tomislav Pavicic; Jelena Culej; Ivan Bolanca; Davorka Herman Mahecic; Lara Milevoj Kopcinovic; Alen Vrtaric
Journal:  Biochem Med (Zagreb)       Date:  2020-06-15       Impact factor: 2.313

3.  Co-expression of 1α-hydroxylase and vitamin D receptor in human articular chondrocytes.

Authors:  Ann Kristin Hansen; Yngve Figenschau; Inigo Zubiaurre-Martinez
Journal:  BMC Musculoskelet Disord       Date:  2017-11-06       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.